Rx Prescription Required
Composition: Cefpodoxime Proxetil 200 mg + Potassium Clavulanate 125 mg
Dosage form: Film-Coated Tablet
Packing: 10 x 10 alu alu Pack
storage: Store in a cool and dry place below 30°C
Third-Party Manufacturing | Wholesale Supply | PCD Franchise
AAKACEF-CV Cefpodoxime Proxetil 200 mg + Potassium Clavulanate 125 mg Tablets
AAKACEF-CV Cefpodoxime Proxetil 200 mg + Potassium Clavulanate 125 mg Tablets is a high-quality pharmaceutical formulation manufactured by AVN Lifesciences. Produced in GMP-compliant manufacturing facilities, this formulation combines Cefpodoxime Proxetil and Potassium Clavulanate to meet stringent pharmaceutical quality standards.
AVN Lifesciences is recognized for delivering reliable pharmaceutical products through advanced manufacturing processes and rigorous quality control systems. AAKACEF-CV is manufactured using premium-grade raw materials and tested at every stage to ensure consistency, safety, and compliance with industry regulations.
As a trusted Cefpodoxime Proxetil and Potassium Clavulanate tablet manufacturer in India, AVN Lifesciences supports healthcare distributors, pharmaceutical marketers, and PCD franchise partners with quality-assured formulations and dependable supply chains. The company also provides third-party manufacturing and contract manufacturing services for businesses looking to expand their pharmaceutical product portfolio.
Aakacef-CV Tablets are commonly used for the treatment of:
Some individuals may experience mild side effects such as
AAKACEF – CV Tablets are available for:
Bulk supply with competitive pricing and consistent quality assurance.